The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment

Experimental Hematology

Volumn 42, Issue 3, 2014, Pages 163-171.e1

  Iwamoto, Chika ^a   Takenaka, Katsuto ^a   Urata, Shingo ^a   Yamauchi, Takuji ^a   Shima, Takahiro ^a   Kuriyama, Takuro ^a   Daitoku, Shinya ^a   Saito, Yasuyuki ^b   Miyamoto, Toshihiro ^a   Iwasaki, Hiromi ^a   Kitabayashi, Issay ^c   Itoh, Katsuhiko ^d   Kishimoto, Junji ^e   Kohda, Daisuke ^e   Matozaki, Takashi ^b,f   Akashi, Koichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CD47 ANTIGEN; MEMBRANE PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOTINYLATION; CONTROLLED STUDY; DNA SEQUENCE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD47; BINDING, COMPETITIVE; CELLS, CULTURED; GRAFT SURVIVAL; HELA CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PHAGOCYTOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84897769541     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.11.005     Document Type: Article

References (43)

1. Ishikawa F., Yoshida S., Saito Y., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007, 25:1315-1321.
2. Manz M.G., Di Santo J.P. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol 2009, 10:1039-1042.
3. Bhatia M., Wang J.C., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997, 94:5320-5325.
4. Guenechea G., Gan O.I., Dorrell C., Dick J.E. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001, 2:75-82.
5. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem Cells 1998, 16:166-177.
6. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
7. Shultz L.D., Schweitzer P.A., Christianson S.W., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995, 154:180-191.
8. Shultz L.D., Lang P.A., Christianson S.W., et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000, 164:2496-2507.
9. Shultz L.D., Banuelos S., Lyons B., et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 2003, 76:1036-1042.
10. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
11. Shultz L.D., Lyons B.L., Burzenski L.M., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005, 174:6477-6489.
12. Ishikawa F., Yasukawa M., Lyons B., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-1573.
13. Christianson S.W., Greiner D.L., Hesselton R.A., et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997, 158:3578-3586.
14. Kollet O., Peled A., Byk T., et al. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000, 95:3102-3105.
15. Ishikawa F., Livingston A.G., Wingard J.R., Nishikawa S., Ogawa M. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice. Exp Hematol 2002, 30:488-494.
16. Takenaka K., Prasolava T.K., Wang J.C., et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007, 8:1313-1323.
17. Strowig T., Rongvaux A., Rathinam C., et al. Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Nat Acad Sci U S A 2011, 108:13218-13223.
18. Brehm M.A., Cuthbert A., Yang C., et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 2010, 135:84-98.
19. Ono A., Hattori S., Kariya R., et al. Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice. J Biomed Biotechnol 2011, 2011:539748.
20. Hesselton R.M., Greiner D.L., Mordes J.P., Rajan T.V., Sullivan J.L., Shultz L.D. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis 1995, 172:974-982.
21. Pearson T., Shultz L.D., Miller D., et al. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol 2008, 154:270-284.
22. Seiffert M., Brossart P., Cant C., et al. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood 2001, 97:2741-2749.
23. Vernon-Wilson E.F., Kee W.J., Willis A.C., Barclay A.N., Simmons D.L., Brown M.H. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur J Immunol 2000, 30:2130-2137.
24. Tsai R.K., Discher D.E. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 2008, 180:989-1003.
25. Matozaki T., Murata Y., Okazawa H., Ohnishi H. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol 2009, 19:72-80.
26. Kuriyama T., Takenaka K., Kohno K., et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood 2012, 120:4058-4067.
27. Yamauchi T., Takenaka K., Urata S., et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013, 121:1316-1325.
28. Motegi S., Okazawa H., Ohnishi H., et al. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J 2003, 22:2634-2644.
29. Enomoto Y., Kitaura J., Shimanuki M., et al. MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPalpha (C/EBPalpha-C(m))-induced myeloid leukemia. Int J Hematol 2012, 96:334-341.
30. Kagiyama Y., Kitaura J., Togami K., et al. Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice. Int J Hematol 2012, 96:638-648.
31. Okazawa H., Motegi S., Ohyama N., et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol 2005, 174:2004-2011.
32. Jaiswal S., Jamieson C.H., Pang W.W., et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009, 138:271-285.
33. Lacks S., Greenberg B. A deoxyribonuclease of Diplococcus pneumoniae specific for methylated DNA. J Biol Chem 1975, 250:4060-4066.
34. Barclay A.N., Brown M.H. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006, 6:457-464.
35. Oshima K., Ruhul Amin A.R., Suzuki A., Hamaguchi M., Matsuda S. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Letters 2002, 519:1-7.
36. Hatherley D., Graham S.C., Harlos K., Stuart D.I., Barclay A.N. Structure of signal-regulatory protein alpha: a link to antigen receptor evolution. J Biol Chem 2009, 284:26613-26619.
37. Nakaishi A., Hirose M., Yoshimura M., et al. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. J Mol Biol 2008, 375:650-660.
38. Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I., Barclay A.N. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell 2008, 31:266-277.
39. Lee W.Y., Weber D.A., Laur O., et al. Novel structural determinants on SIRP alpha that mediate binding to CD47. J Immunol 2007, 179:7741-7750.
40. Liu Y., Tong Q., Zhou Y., et al. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47. J Mol Biol 2007, 365:680-693.
41. Hatherley D., Harlos K., Dunlop D.C., Stuart D.I., Barclay A.N. The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J Biol Chem 2007, 282:14567-14575.
42. Theocharides A.P., Jin L., Cheng P.Y., et al. Disruption of SIRPalpha signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J Exp Med 2012, 209:1883-1899.
43. Majeti R., Chao M.P., Alizadeh A.A., et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009, 138:286-299.